VJHemOnc is committed to improving our service to you

EHA 2019 | Novel therapies targeting the innate immune system in MDS

VJHemOnc is committed to improving our service to you

Alan List

Alan List, MD, from the Moffitt Cancer Center, Tampa, FL, talks about new therapies that have the potential to target the innate immune system in myelodysplastic syndromes (MDS). This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter